⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1660 | 1.00 | — | — | |
| SCHEMBL1661 | 1.00 | — | — | |
| SCHEMBL3798436 | 0.71 | — | — | |
| SCHEMBL7670833 | 0.71 | — | — | |
| SCHEMBL7670830 | 0.71 | — | — | |
| SCHEMBL8829614 | 0.69 | — | — | |
| SCHEMBL9615377 | 0.69 | — | — | |
| SCHEMBL11451075 | 0.69 | — | — | |
| SCHEMBL6578754 | 0.69 | — | — | |
| SCHEMBL725434 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7199105-B2 | Lincomycin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS, INC. (US) | 2007-04-03 | — | — | US | claimed |
| EP-0439096-B1 | Improvements in or relating to beta lactam production | BIOCHEMIE GMBH (AT) | 2003-12-17 | — | — | EP | claimed |
| US-5276024-A | 3-substituted cephalosporins, and their use as medicaments | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-04 | — | — | US | claimed |
| US-4789758-A | Process for the production of an N-protected-L-α-aspartyl-L-phenylalanine | AJINOMOTO CO., INC. (JP) | 1988-12-06 | — | — | US | claimed |
| US-4740616-A | Process for the production of an N-protected-L-α-aspartyl-L-phenylalanine | AJINOMOTO CO., INC. (JP) | 1988-04-26 | — | — | US | claimed |
| US-4680403-A | Process for producing N-protected-α-L-aspartyl-L-phenylalanine methyl ester | AJINOMOTO CO., INC. (JP) | 1987-07-14 | — | — | US | claimed |
| JP-7165684-A | — | — | None | — | — | JP | disclosed |
| JP-7070177-A | — | — | None | — | — | JP | disclosed |
| EP-2464623-B1 | THE RING OPENING OF LACTONES AND LACTAMS | NOVARTIS AG (CH) | 2020-11-04 | — | — | EP | disclosed |
| US-8779198-B2 | Ring opening of lactones and lactams | NOVARTIS AG (CH) | 2014-07-15 | — | — | US | disclosed |
| US-8507673-B2 | Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compounds | EMORY UNIVERSITY (US) | 2013-08-13 | — | — | US | disclosed |
| US-20120165555-A1 | RING OPENING OF LACTONES AND LACTAMS | NOVARTIS AG (CH) | 2012-06-28 | — | — | US | disclosed |
| US-20120041198-A1 | Process for Preparing 5,7 Diaminopyrazolo [1,5-a] Pyrimidine Compounds | EMORY UNIVERSITY | 2012-02-16 | — | — | US | disclosed |
| EP-0041047-A2 | Dioxide compounds, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1981-12-02 | — | — | EP | disclosed |
| EP-0034347-A2 | Derivatives of aldohexoses, intermediates, process for their production, preparations containing such compositions and their use | CIBA-GEIGY AG (CH) | 1981-08-26 | — | — | EP | disclosed |
| EP-0031794-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1981-07-08 | — | — | EP | disclosed |
| US-4264498-A | REACTED WITH AN ACID, ITS ACID HALIDE, OR ANHYDRIDE IN THE PRESENCE OF BORON TRIHALIDE AND AN ORGANIC BASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
| US-3937718-A | CARBOXYLIC ACIDS, ALCOHOLS, TERTIERY PHOSPHINES, DISULFIDES, SULFENIC ACID ESTER | SANKYO COMPANY LIMITED (JA) | 1976-02-10 | — | — | US | disclosed |
| US-3936447-A | 7-Acylamino-desacetoxy-cephalosporanic acid esters and their production | BAYER AKTIENGESELLSCHAFT (DT) | 1976-02-03 | — | — | US | disclosed |
| US-3932439-A | N-substituted cycloserine compounds, salts thereof, and processes for preparing them | MERCK & CO., INC. (US) | 1976-01-13 | — | — | US | disclosed |